European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab-EUROTRANSFER Registry

American Heart Journal

Volumn 156, Issue 6, 2008, Pages 1147-1154

  Dudek, Dariusz ^a   Siudak, Zbigniew ^a   Janzon, Magnus ^b   Birkemeyer, Ralf ^c   Aldama Lopez, Guillermo ^d   Lettieri, Corrado ^e   Janus, Bogdan ^f   Wisniewski, Andrzej ^f   Berti, Sergio ^g   Olivari, Zoran ^h   Rakowski, Tomasz ^a   Partyka, Lukasz ^a   Goedicke, Jochen ⁱ   Zmudka, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c SCHWARZWALD BAAR KLINIKUM   (Germany)

^d HOSPITAL JUAN CANALEJO   (Spain)

^e CARLO POMA HOSPITAL   (Italy)

^f Specjalistyczny Szpital im E Szczeklika ^*  (Poland)

^g G PASQUINUCCI HOSPITAL   (Italy)

^h OSPEDALE CA FONCELLO   (Italy)

ⁱ Eli Lilly Critical Care Europe   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; EUROPE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRIORITY JOURNAL; REGISTER; ST SEGMENT ELEVATION; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HOSPITAL MORTALITY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL ANALYSIS; TIME AND MOTION STUDIES;

EID: 56349134903     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.08.004     Document Type: Article

References (11)

1. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367 (2006) 569-578
2. Antman E.A., Hand M., Armstrong P.W., et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 117 (2008) 296-329
3. Ellis S.G., Tendera M., de Belder M.A., et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 358 (2008) 2205-2217
4. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
5. Flynn M.R., Barrett C., Cosio F.G., et al. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J 26 (2005) 308-313
6. Antoniucci D., Valenti R., Migliorini A., et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 89 (2002) 1248-1252
7. D'Agostino Jr. R.B. Tutorial in Biostatistics-Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
8. Heer T., Zeymer U., Juenger C., et al. Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice. Heart 92 (2006) 1484-1489
9. Tornvall P., Nilsson T., and Lagerqvist B. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation. J Intern Med 260 (2006) 363-368
10. Gersh B.J., Stone G.W., White H.D., et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?. JAMA 293 (2005) 979-986
11. Steg P.G., López-Sendón J., Lopez de Sa E., et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 167 (2007) 68-73